+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Drug Discovery Informatics Market by Solutions, Functions, End-User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887835
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug Discovery Informatics Market grew from USD 2.90 billion in 2023 to USD 3.19 billion in 2024. It is expected to continue growing at a CAGR of 9.92%, reaching USD 5.64 billion by 2030.

Drug Discovery Informatics is a critical field that integrates data analysis and computational technologies to streamline the drug discovery process. The scope of this domain encompasses a broad range of activities, including target identification, lead optimization, and data management, all aimed at accelerating the identification and development of new pharmaceuticals. Its necessity stems from the increasing complexity and volume of biological data generated, necessitating advanced informatics tools to make sense of this data and drive efficient drug development. Applications primarily include pharmaceutical companies, biotechnology firms, and research institutions, with end-use extending to personalized medicine, predictive analytics, and bioinformatics.

Market insights reveal several key factors influencing growth in drug discovery informatics. The advent of AI and machine learning is pivotal, enabling more precise predictions in molecular behavior and interactions. Additionally, the rise of big data and cloud computing infrastructure provides unprecedented data storage and processing capabilities, propelling market demand. Potential opportunities lie in the expansion of personalized medicine, where informatics can tailor drug treatments to individual genetic profiles. Market players can capitalize on collaborations with tech companies to enhance algorithm development and leverage data sharing for innovation.

However, challenges such as data privacy concerns, high initial implementation costs, and integration issues with legacy systems can impede market growth. Moreover, the constant evolution of software solutions requires ongoing investment in research and development, posing financial and operational risks.

For business growth, innovation should focus on developing robust, user-friendly informatics platforms capable of integrating multi-omics data, enabling holistic understanding of drug interactions. Additionally, establishing strategic partnerships with academic and tech institutions for collaborative research can open new frontiers in drug discovery informatics. The market is characterized by rapid technological advancement and increasing competition, but offers expansive growth potential for companies willing to invest in cutting-edge solutions and strategic alliances.

Understanding Market Dynamics in the Drug Discovery Informatics Market

The Drug Discovery Informatics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing need for precision medicine in rare and orphan disease management
    • Favorable government support for drug discovery procedures
    • Rising use of bioinformatic software for drug discovery and development
  • Market Restraints
    • Involvement of huge cost for development of bio-informatic infrastructure
  • Market Opportunities
    • Potential research investments for the development of drug discovery informatics
    • Integration of next-generation technologies in drug discovery procedures
  • Market Challenges
    • Lack of skilled and experienced professionals

Exploring Porter’s Five Forces for the Drug Discovery Informatics Market

Porter’s Five Forces framework further strengthens the insights of the Drug Discovery Informatics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Drug Discovery Informatics Market

External macro-environmental factors deeply influence the performance of the Drug Discovery Informatics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Drug Discovery Informatics Market

The Drug Discovery Informatics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Discovery Informatics Market

The Drug Discovery Informatics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Drug Discovery Informatics Market

The Drug Discovery Informatics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systèmes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrödinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Solutions
    • Services
    • Software
  • Functions
    • Docking
    • Libraries & Database Preparation
    • Molecular Modeling
    • Sequencing & Target Data Analysis
  • End-User
    • Contract Research Organizations (CRO)
    • Pharmaceutical & Biotechnology Companies
  • Application
    • Drug Development
      • Clinical Trials
      • Preclinical Testing
    • Drug Discovery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
5.1.1.2. Favorable government support for drug discovery procedures
5.1.1.3. Rising use of bioinformatic software for drug discovery and development
5.1.2. Restraints
5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
5.1.3. Opportunities
5.1.3.1. Potential research investments for the development of drug discovery informatics
5.1.3.2. Integration of next-generation technologies in drug discovery procedures
5.1.4. Challenges
5.1.4.1. Lack of skilled and experienced professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Drug Discovery Informatics Market, by Solutions
6.1. Introduction
6.2. Services
6.3. Software
7. Drug Discovery Informatics Market, by Functions
7.1. Introduction
7.2. Docking
7.3. Libraries & Database Preparation
7.4. Molecular Modeling
7.5. Sequencing & Target Data Analysis
8. Drug Discovery Informatics Market, by End-User
8.1. Introduction
8.2. Contract Research Organizations (CRO)
8.3. Pharmaceutical & Biotechnology Companies
9. Drug Discovery Informatics Market, by Application
9.1. Introduction
9.2. Drug Development
9.2.1. Clinical Trials
9.2.2. Preclinical Testing
9.3. Drug Discovery
10. Americas Drug Discovery Informatics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Discovery Informatics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Discovery Informatics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DRUG DISCOVERY INFORMATICS MARKET RESEARCH PROCESS
FIGURE 2. DRUG DISCOVERY INFORMATICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG DISCOVERY INFORMATICS MARKET DYNAMICS
TABLE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DOCKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY LIBRARIES & DATABASE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CRO), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 40. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 41. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 42. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 45. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 67. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 68. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 69. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 72. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 73. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 74. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 82. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 83. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 112. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 113. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 129. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 133. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 134. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 138. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 139. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 143. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 148. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 159. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 160. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 173. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 174. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 179. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 180. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 183. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 184. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 185. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 203. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 204. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 218. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 219. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 233. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Drug Discovery Informatics Market, which are profiled in this report, include:
  • Accenture PLC
  • Agilent Technologies, Inc.
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadence Design Systems, Inc.
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Cognizant Technology Solutions Corporation
  • Collaborative Drug Discovery, Inc
  • Crown Bioscience, Inc.
  • Dassault Systèmes SE
  • Eurofins DiscoverX Products LLC
  • Evotec AG
  • Illumina, Inc.
  • Infosys Limited
  • InSilico Medicine
  • International Business Machines Corporation
  • Jubilant Biosys Ltd.
  • Oracle Corporation
  • PerkinElmer Inc.
  • Schrödinger, Inc.
  • Selvita S.A.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information